Market Overview

Map Pharmaceuticals Spikes Higher

Related MAPP
UPDATE: Wedbush Downgrades MAP Pharmaceuticals to Neutral, Reiterates $25 PT on Likely Acquisition
2013: Year of the Mega Deal

Posted-In: News

 

Related Articles (MAPP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters